KeyGene’s patent portfolio is a cornerstone of innovation in genomics, focusing on advanced techniques in NGS (Next Generation Sequencing), genotyping, gene editing, etc.
These patents drive breakthroughs, enabling applications in healthcare, diagnostics, agriculture, and beyond. KeyGene’s intellectual property fuels progress in understanding genetic variation, shaping the future of various fields with tailored solutions.
Genotyping SNP, SSR and indel polymorphisms in a single streamlined process for multiple samples.
Multiplex detection of variation of genes / loci of interest, based on high throughput sequencing.
Genotyping, based upon locus & allele identifiers; a way to amplify and process DNA into probes
Method to effectively deliver mutagenic nucleobases to plant protoplasts using polyethylene glycol
At least two nucleotide sequence barcodes, for identifying sample origin in NGS.
Translocation between 2 homologous/homeologous chromosomes via double-strand break and rejoining
Glycerol free genome editing of protoplasts using CRISPR-CAS protein and in vitro transcribed gRNA
Genome editing using cysteine or adenine deaminase fused to a site-specific nuclease e.g. a CAS
Production of oligonucleotides, in particular targeting oligonucleotides or nucleic acid probes.
Editing of a coding sequence by two site-specific nucleases that causes a frameshift
Highly effective Type V CRISPR system for plant cell genome editing
Effective genome editing CRISPR system nuclease guided by non-covalently linked, crRNA and tracrRNA
Versatile method for the labelling of a target nucleic acid fragment for targeted sequence library preparation
For methods and kits for HMW nucleic acid library preparation, effectively reducing shear stress.
TelN adapters / primers for NGS library preparation for amplification free enrichment of target sequences.